Riskpilot← Back to searchSign inGet full accessCARDIOMECH AS
ASActiveOrg 915653197Cort Adelers Gate 33, 0254 OsloManufacture of medical and dental instruments and supplies · NACE 3250Est. 20153 employees
Revenue 2024
NOK 0
EBITDA margin
—
-5% vs 2023
Equity ratio
11.3%
Financial strength
Net profit 2024
NOK -54,4M
-163% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -15,9M | -5% |
| Net profit | NOK -54,4M | -163% |
| Total assets | NOK 358,9M | +1% |
| Equity | NOK 40,7M | -57% |
| Employees | 3 | — |
Legal name
CARDIOMECH AS
Org number
915653197
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
10. juli 2015
Share capital
NOK 132 439
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikling av medisinske prosedyrer og utstyr for bruk i pasientbehandling og det som naturlig faller inn under dette.
Address
Cort Adelers Gate 33, 0254 Oslo
Phone
+4795555339
Email
huayinqiu@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 109 | 220 | 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −692 | −0 | −0 | −0 | −0 | −6 679 | −6 383 |
| EBITDA | −109 | −191 | −141 | −1 302 | −13 725 | −16 353 | −7 022 | −9 994 | −15 055 | −15 872 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −109 | −191 | −141 | −1 302 | −13 725 | −16 353 | −7 022 | −9 994 | −15 055 | −15 872 |
| Net financials | −2 | −0 | −2 | −51 | −100 | −2 344 | 441 | −2 332 | −5 649 | −38 551 |
| Profit before tax | −111 | −191 | −143 | −1 353 | −13 825 | −18 698 | −6 581 | −12 326 | −20 704 | −54 423 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −111 | −191 | −143 | −1 353 | −13 825 | −18 698 | −6 581 | −12 326 | −20 704 | −54 423 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 47 | 202 | 85 | 11 470 | 59 937 | 140 261 | 132 794 | 184 320 | 356 781 | 358 891 |
| Equity | −95 | 202 | 59 | −1 087 | −14 912 | 134 756 | 128 175 | 115 849 | 95 145 | 40 722 |
| Long-term debt | 0 | 0 | 0 | 10 513 | 66 072 | 0 | 0 | 58 458 | 238 362 | 268 291 |
| Short-term debt | 141 | 0 | 27 | 2 044 | 8 777 | 5 504 | 4 618 | 10 013 | 23 274 | 49 878 |
| Total debt | 141 | 0 | 27 | 12 557 | 74 849 | 5 504 | 4 618 | 68 471 | 261 636 | 318 169 |
EBITDA margin
-1587179100.0%
This company
15.8%
Market median
-10045437442% vs market
20152024
Equity ratio
11.3%
This company
38.2%
Market median
-70% vs market
20152024
Return on equity
-133.6%
This company
18.4%
Market median
-826% vs market
20152024
Net profit margin
-5442325600.0%
This company
8.1%
Market median
-67189205038% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
7.81×
This company
0.62×
Market median
-1160% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2023 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nihi As | Company | 14.7% | 14.7% | 2024 |
Richard Nehm | Company | 13.2% | 13.2% | 2024 |
Jacob Bergsland Holding As | Company | 10.9% | 10.9% | 2024 |
Abbott Laboratories | Company | 10.8% | 10.8% | 2024 |
Investinor Indirekte Ii As | Company | 5.0% | 5.0% | 2024 |
Peak One Consulting Llc | Company | 4.2% | 4.2% | 2024 |
Helift As | Company | 4.0% | 4.0% | 2024 |
Investitude As | Company | 3.5% | 3.5% | 2024 |
Hadean Capital I As | Company | 3.5% | 3.5% | 2024 |
Cardio Ventures Gmbh & Co Kg | Company | 3.1% | 3.1% | 2024 |
The Strategyst Venture Srl | Company | 2.5% | 2.5% | 2024 |
| Individual | 1.7% | 1.7% | 2022 | |
Eliga Limited Partnership | Company | 1.7% | 1.7% | 2024 |
Gunnar Pah | Company | 1.6% | 1.6% | 2024 |
Hventures Capital I Ab | Company | 1.6% | 1.6% | 2024 |
Vic Bertrand Jr. | Company | 1.4% | 1.4% | 2024 |
Swan Capital Inc | Company | 1.3% | 1.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CARDIOMECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jacob Bergsland | Board of Directors | 0 companies |
| Vic Joseph Bertrand | Board of Directors | 0 companies |
| Florian Eckhardt | Board of Directors | 0 companies |
| Jan Trygve Håbrekke | Board of Directors | 0 companies |
| Ingrid Helene Teigland Akay | Board of Directors | 0 companies |
| Richard David Nehm | Chairman | 0 companies |
| Mark Alan Novotny | Chairman | 0 companies |